Cargando…
Can Drug Repurposing be Effective Against Carbapenem-Resistant Acinetobacter baumannii?
Carbapenem-resistant Acinetobacter baumannii has been classified as a top priority for the development of new therapies due to its resistance to most antibiotics. Drug repurposing may be a fast and inexpensive strategy for treating this pathogen. This review aims to critically evaluate repurposed dr...
Autores principales: | Gontijo, Aline Vidal Lacerda, Pereira, Sharlene Lopes, de Lacerda Bonfante, Herval |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669236/ https://www.ncbi.nlm.nih.gov/pubmed/34905109 http://dx.doi.org/10.1007/s00284-021-02693-5 |
Ejemplares similares
-
Repurposed dihydroorotate dehydrogenase inhibitors with efficacy against drug-resistant Acinetobacter baumannii
por: Russo, Thomas A., et al.
Publicado: (2022) -
Comparison between Colistin and Polymyxin B in the Treatment of Bloodstream Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii-calcoaceticus Complex
por: Garcia, Rebeca Carvalho Lacerda, et al.
Publicado: (2023) -
Repurposing Screen Identifies Unconventional Drugs With Activity Against Multidrug Resistant Acinetobacter baumannii
por: Cheng, Yu-Shan, et al.
Publicado: (2019) -
Antimicrobial Activity of a Repurposed Harmine-Derived Compound on Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates
por: Breine, Anke, et al.
Publicado: (2022) -
In Vitro and In Vivo Activity of AS101 against Carbapenem-Resistant Acinetobacter baumannii
por: Yang, Tsung-Ying, et al.
Publicado: (2021)